Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Other · France
Declared costs: €25K+ a year · in the register since 2018
Industry association · Spain
Declared costs: €100K+ a year · in the register since 2015
European Biotech Act · Compulsory licensing of patents in crisis situations · Supplementary protection certificate for plant protection products. Recast
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
CNCPI · filed 11 Jun 2025 · source
Compagnie nationale des agents en propriété industrielle (CNCPI) is the French official body comprising all industrial property agents, namely the liberal professionals specialising in industrial property operating in France. In the context of the public consultation on the European Biotech Act, the CNCPI wishes to bring the attached position paper to the attention of the European Commission.
Filed in French · English published by the European Commission
Farmaindustria · filed 13 Jul 2026 · source
Farmaindustria appreciates the Regulation for its potential to strengthen the EU’s competitiveness, strategic autonomy and innovation capacity, although it could be more ambitious in the face of increasing global competition and investment pressure from other regions.
Filed in Spanish · English published by the European Commission
CNCPI · filed 29 Apr 2022 · source
The CNCPI, a body set up by the French Intellectual Property Code and representing the regulated liberal profession of all French patent agents, thanked the European Commission for the opportunity to participate in this call for contributions and welcomed its willingness to consult with a view to possible legislative work on compulsory patent licences.
Filed in French · English published by the European Commission
Farmaindustria · filed 28 Jul 2023 · source
The EC proposal on the granting of compulsory licences (LO) is of great concern to FARMAINDUSTRIA by providing for the suspension of IP rights and preventing the choice of partners to voluntarily grant manufacturing licences for their products without any legal basis being observed to limit the use of this measure.
Filed in Spanish · English published by the European Commission
Farmaindustria · filed 26 Mar 2022 · source
Making new therapies available to patients is a long, complex and risky process that requires considerable investment, giving industrial protection — and the period for which it is effective — a key role in embarking on this process.
Filed in Spanish · English published by the European Commission
CNCPI · filed 5 Apr 2022 · source
The CNCPI, a body representing the regulated liberal profession comprising all French patent agents, thanks the European Commission for the opportunity to participate in this call for contributions and welcomes its desire to review the system for granting supplementary protection certificates (SPCs).
Filed in French · English published by the European Commission
Farmaindustria · filed 18 Sept 2023 · source
Farmaindustria, as the representative of the innovative pharmaceutical industry established in Spain, welcomes the proposed revision of the SPC Regulation of, given its objective of creating a harmonised and centralised approach to the application, evaluation and granting of SPC for both classical European and unitary patents (UPs), providing a clearer and more efficient framework for industrial property in the EU…
Filed in Spanish · English published by the European Commission
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.